| 1.45 -0.03 (-2.03%) | 10-22 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.18 | 1-year : | 2.7 |
| Resists | First : | 1.86 | Second : | 2.31 |
| Pivot price | 1.64 |
|||
| Supports | First : | 1.13 | Second : | 0.94 |
| MAs | MA(5) : | 1.51 |
MA(20) : | 1.61  |
| MA(100) : | 0.95 |
MA(250) : | 0.95 |
|
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 5.3 |
D(3) : | 12.9 |
| RSI | RSI(14): 47.8 |
|||
| 52-week | High : | 2.31 | Low : | 0.34 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ TLRY ] has closed above bottom band by 17.3%. Bollinger Bands are 28% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.48 - 1.49 | 1.49 - 1.5 |
| Low: | 1.38 - 1.39 | 1.39 - 1.4 |
| Close: | 1.44 - 1.45 | 1.45 - 1.46 |
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Wed, 22 Oct 2025
Tilray Brands, Inc. (TLRY): A Bull Case Theory - Insider Monkey
Tue, 21 Oct 2025
Tilray Brands (NASDAQ:TLRY) Shares Down 5.7% - What's Next? - MarketBeat
Tue, 21 Oct 2025
Tilray’s Financial Fall: Time To Re-evaluate? - StocksToTrade
Tue, 21 Oct 2025
Tilray Brands (TSE:TLRY) Trading Up 1.4% - Time to Buy? - MarketBeat
Wed, 15 Oct 2025
Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 1,120 (M) |
| Shares Float | 1,110 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 9.7 (%) |
| Shares Short | 132,830 (K) |
| Shares Short P.Month | 161,900 (K) |
| EPS | -2.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.37 |
| Profit Margin | -258.6 % |
| Operating Margin | -5.1 % |
| Return on Assets (ttm) | -1.8 % |
| Return on Equity (ttm) | -85.8 % |
| Qtrly Rev. Growth | 4.6 % |
| Gross Profit (p.s.) | 0.21 |
| Sales Per Share | 0.74 |
| EBITDA (p.s.) | 0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -61 (M) |
| Levered Free Cash Flow | 25 (M) |
| PE Ratio | -0.6 |
| PEG Ratio | 0 |
| Price to Book value | 1.05 |
| Price to Sales | 1.95 |
| Price to Cash Flow | -26.79 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|